Astragalus Sarcocola

Astragalus sarcocola  Dymock.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Fabaceae; Papilionaceae.
Habitat The mountainous regions from Asia Minor to Iraq and Iran.
English Sarcocola.
Ayurvedic Rudanti (substitute).
Unani Anzaroot, Kohal Kirmaani (Gum).
Action Gum—antirheumatic, aperient, anthelmintic, emollient.
Taxonomic Cohort Genus Astragalus (5 documented species); Family Fabaceae (25 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Astragalus sarcocola (taxonomically cited with authority Dymock.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Fabaceae; Papilionaceae (primary family classification: Fabaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: The mountainous regions from Asia Minor to Iraq and Iran.

Across classical and vernacular Indian systems of medicine, Astragalus sarcocola is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Sarcocola; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Rudanti (substitute); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Anzaroot, Kohal Kirmaani (Gum). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Astragalus sarcocola are: Gum—antirheumatic, aperient, anthelmintic, emollient. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

The therapeutic activity of Astragalus sarcocola is grounded in its documented pharmacological actions (Gum—antirheumatic, aperient, anthelmintic, emollient) and the characteristic secondary metabolite profile of the family Fabaceae.

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Astragalus comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Astragalus candolleanus (Action: Depurative, bechic, blood purifier (used in skin diseases). Root powder and…); Astragalus gummifer (Action: Demulcent, emollient (used for irritation of the internal mucosa, colitis, dry…); Astragalus hamosus (Action: Nervine tonic (used in nervous and catarrhal affections), antirheumatic…); Astragalus strobiliferus (Action: Gum—an Indian substitute for tragacanth (A. gummifer gum)). Comparing Astragalus sarcocola alongside its congeners in genus Astragalus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Fabaceae encompasses 25 documented medicinal species (1.38% of the 1,814-species flora). Other representative medicinal members of Fabaceae include: Astragalus candolleanus (Rudanti), Astragalus gummifer (Tragacanth Gum), Astragalus hamosus (Tonkin bean), Astragalus strobiliferus (Indian Gum tragacanth), Cyamopsis tetragonoloba (Kshudra Shimbi). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 25 medicinal species of family Fabaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Astragalus sarcocola follow the plant-part modalities specified under its therapeutic action (Gum—antirheumatic, aperient, anthelmintic, emollient), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Astragalus sarcocola integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top